Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will make it his policy to procure a vaccine against covid-19 which has not involved the use of human embryo cells in its development; if he will encourage the use of (a) adult stem cells and (b) synthetic methods in vaccine development; and if he will make a statement.

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that the Oxford University/AstraZeneca, Moderna, and Pfizer/BioNTech COVID-19 vaccines, which have all received regulatory approval, do not contain any components of animal origin, and no foetal material is present in the final vaccine.